Oral Abstract Session
Bone and Mineral Metabolism: Emerging Mechanisms and Disease
October 22, 2026 | 04:30 PM - 06:00 PM
Location: Room 405, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- Bones‚ Stones‚ and Mineral Metabolism
Moderators
Presentations
HNF4α2 Is a Transcriptional Repressor of Fibroblast Growth Factor 23 (FGF-23)
Rethinking Fibroblast Growth Factor 23 Cleavage: The Biological Role of the N-Terminal FGF-23 Peptide in Bone and Mineral Metabolism
α-Klotho Forms Dimers for Fibroblast Growth Factor 23 (FGF-23) Bivalent Binding and Maximal Response
Selective Inhibition of NaPi-IIa Promotes Phosphaturia in Normo- and Hyperphosphatemic Rats and Reduces Calcifications and Increases Survival in Klotho-Deficient Mice
Intestinal Vitamin D Receptor Deficiency Enhances Intestinal Phosphorus Absorption to Exacerbate Systemic Phosphorus Load
Indoxyl Sulfate Disrupts Mitochondrial Metabolic Adaptation During Osteoblast Differentiation in CKD
MicroRNAs (miRs) Do Not Enhance Identification of Low Turnover by Traditional Biomarkers in Patients with Renal Osteodystrophy (ROD)
Human Genetics Identify TBX2 as a Key Regulator of Vascular Calcification by Orchestrating Mineral Metabolism and Inflammation
Serum Calciprotein Particle Level and Coronary Artery Calcification Among Patients with CKD: The CRIC Study